Transcenta Holding announced that its HJB subsidiary in-licensed China rights to a portfolio of novel bone disease biotherapeutics from Eli Lilly. Medtronic, a medical device maker, has launched …
( read original story …)
The HongKong News
Transcenta Holding announced that its HJB subsidiary in-licensed China rights to a portfolio of novel bone disease biotherapeutics from Eli Lilly. Medtronic, a medical device maker, has launched …
( read original story …)